ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19

The severity of the new COVID-19 pandemic caused by the SARS-CoV-2 virus is strikingly variable in different global populations. SARS-CoV-2 uses ACE2 as a cell receptor, TMPRSS2 protease, and FURIN peptidase to invade human cells. Here, we investigated 1,378 whole-exome sequences of individuals from...

詳細記述

保存先:
書誌詳細
出版年:Heliyon
主要な著者: Al-Mulla, Fahd, Mohammad, Anwar, Al Madhoun, Ashraf, Haddad, Dania, Ali, Hamad, Eaaswarkhanth, Muthukrishnan, John, Sumi Elsa, Nizam, Rasheeba, Channanath, Arshad, Abu-Farha, Mohamed, Ahmad, Rasheed, Abubaker, Jehad, Thanaraj, Thangavel Alphonse
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2021
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843038/
https://ncbi.nlm.nih.gov/pubmed/33532652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2021.e06133
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料